why choose us

First received: January 11, 2023

Clinical Trial: Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC

Study Status: Completed

Recruit Status: RECRUITING

Condition: NSCLC Stage IV

Study Type: INTERVENTIONAL


Official Title: A Phase II Trial of Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC

Brief Summary: The purpose of this study is to test if low dose radiation, which is routinely used in treating patients with lung cancer for symptom control, can improve the results from the standard treatment with pembrolizumab and chemotherapy.In this study, only individuals who have NSCLC that is advanced (Stage IV), or has come back (recurred), will be able to participate.

Read more